These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 23873424

  • 1. Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Dąbkowska-Huć A, Lemm M, Sikora J, Witek A, Skałba P.
    Endokrynol Pol; 2013; 64(3):203-7. PubMed ID: 23873424
    [Abstract] [Full Text] [Related]

  • 2. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [Abstract] [Full Text] [Related]

  • 3. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [Abstract] [Full Text] [Related]

  • 4. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Jan; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 5. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 6. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A, Margalioth EJ, Chetrit AB, Gal M, Goldberg D, Alerhand S, Eldar-Geva T.
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 8. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 9. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F, Liu XL, Rong N, Huang XW.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [Abstract] [Full Text] [Related]

  • 12. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A, Abou-Salem N.
    Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
    [Abstract] [Full Text] [Related]

  • 13. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M, López N, Noguera JA, Mendiola J, Hernández AI, Corbalán S, Sanchez M, Torres AM.
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [Abstract] [Full Text] [Related]

  • 14. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.
    Elmashad AI.
    Fertil Steril; 2011 Jun; 95(7):2342-6, 2346.e1. PubMed ID: 21514928
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 16. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA, Mahran A, Abdelmaged A, El-Adawy AR, Eissa MK, Shaw RW.
    Reprod Biol Endocrinol; 2013 Dec 17; 11():115. PubMed ID: 24341292
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats.
    Shi Y, Li L, Zhou J, Sun J, Chen L, Zhao J, Wu L, Cui Y, Wu L, Wu H.
    Biomed Pharmacother; 2019 May 17; 113():108687. PubMed ID: 30851546
    [Abstract] [Full Text] [Related]

  • 18. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN.
    Hum Reprod; 2008 Apr 17; 23(4):952-7. PubMed ID: 18256110
    [Abstract] [Full Text] [Related]

  • 19. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 17; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 20. Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Xi W, Yang Y, Mao H, Zhao X, Liu M, Fu S.
    J Ovarian Res; 2016 Feb 11; 9():3. PubMed ID: 26864649
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.